UCLA launches groundbreaking clinical trial for vaccine targeting aggressive pediatric brain cancer

In an effort to combat one of the most lethal forms of pediatric brain cancer, researchers at the UCLA Health Jonsson Comprehensive Cancer Center are launching a first-of-its-kind clinical trial to evaluate the safety and effectiveness of a cancer vaccine targeting H3 G34-mutant diffuse hemispheric glioma, a highly aggressive brain tumor that is typically found in adolescents and young adults.

NIDDK Catalyst Award funds research on mammary gland’s role in metabolic diseases

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Catalyst Award program has awarded a $4 million, five-year grant to Prashant Rajbhandari, PhD,

August 27, 2024

ReflexAI Launches AI Tool to Prevent Veteran Suicide

What You Should Know: ReflexAI, the leading provider of AI-powered training and quality assurance tools for crisis response, emergency dispatch, and healthcare organizations, launched HomeTeam, a

November 9, 2023

Opinion | Ending Oncology’s Toxic Relationship With High Chemotherapy Doses

Sekeres is a leukemia specialist. Many years ago, my patient, a woman in her fifties with chronic myeloid leukemia (CML), got her routine, yearly lab

May 11, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.